✦ LIBER ✦

Outcomes and cost-effectiveness: The Payer's perspective

✍ Scribed by Cutler, Charles M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMS34 COST-EFFECTIVENESS OF GOLIMUMAB IN

✍ E Cummins; C Asseburg; M Prasad; J Buchanan; Y Punekar 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

PSY38 COST-EFFECTIVENESS OF GOLIMUMAB IN

✍ Muszbek, N; Punekar, Y; Buchanan, J; Prasad, M; Vioix, H; Brown, R 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

PHP65 THE IMPACT AND CHALLENGES OF INCLU

✍ DE Spackman; JD Campbell 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

The Cost-Effectiveness of Duloxetine in

✍ Wielage, Ronald C.; Bansal, Megha; Andrews, J. Scott; Wohlreich, Madelaine M.; K 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 851 KB

The Cost-Effectiveness of Duloxetine in

✍ Liedgens, Hiltrud; Henske, Rainer 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 240 KB

Comparing the cost-effectiveness of two

✍ Vuong, Duong Anh; Rades, Dirk; van Eck, Albertus T.C.; Horstmann, Gerhard A.; Bu 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 642 KB